Home›Nutrition & Obesity Medicine› Bovine milk fortifiers non-inferior to human milk fortifiers for NEC and sepsis in pre-term newborns
Bovine milk fortifiers non-inferior to human milk fortifiers for NEC and sepsis in pre-term newbornsBovine Milk Fortifiers Show Similar Results to Human Milk
medRxivPublished June 29, 2026Study authors: Ni, D.; Ge, A.; Mishra, A.; Oei, J. L.; Nanan, R.DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider bovine milk-based fortifiers as a non-inferior alternative to human milk-based fortifiers for NEC and sepsis outcomes in pre-term newborns.
This meta-analysis, analyzing 3371 PubMed-indexed publications, evaluated whether bovine milk-based fortifiers (BMF) are non-inferior to human milk-based fortifiers (HMF) for necrotizing enterocolitis (NEC) and sepsis outcomes in pre-term newborns. The primary outcome was non-inferiority of BMF to HMF for NEC and sepsis outcomes, and the results indicated non-inferiority, though specific effect sizes, absolute numbers, and confidence intervals were not reported.
The authors note that prior systematic reviews and meta-analyses generally reported mixed findings comparing HMF versus BMF, highlighting the need for further clarity. This analysis serves as a proof-of-concept example for LLM AI-assisted meta-research and evidence synthesis, supporting integration of such methodologies into evidence-based medicine and digital health.
Limitations include the lack of reported effect sizes, p-values, and confidence intervals, which limits the ability to assess the strength of the evidence. Additionally, safety data, adverse events, and follow-up duration were not reported. The findings should be interpreted cautiously, and clinicians should consider individual patient factors when choosing between BMF and HMF.
How this fits prior evidence
This meta-analysis extends prior coverage on neonatal sepsis and NEC by directly comparing nutritional interventions. Prior coverage highlighted that elevated HMGB1 levels correlate with sepsis diagnosis and mortality in adults, and that neutrophil extracellular traps contribute to vascular dysfunction in sepsis. Additionally, AI models showed moderate sensitivity (0.78) and specificity (0.84) for diagnosing NEC, and vitamin D deficiency increased sepsis risk in neonates. The current finding that BMF is non-inferior to HMF for NEC and sepsis outcomes provides a practical nutritional strategy, contrasting with the diagnostic and mechanistic focus of prior items.
Researchers looked at a large collection of studies involving pre-term newborns. They specifically compared the use of bovine milk based fortifiers (BMF) against human milk based fortifiers (HMF). The goal was to see if BMF provided similar outcomes for babies facing serious conditions like necrotizing enterocolitis and sepsis.
The analysis of over 3,000 publications found that BMF did not perform worse than HMF in these cases. This means the two types of fortifiers showed similar results regarding these specific health risks. While previous reviews on this topic had shown mixed results, this large scale review provided a more consistent look at the data.
It is important to note that this study was primarily used as a proof of concept for using artificial intelligence to help organize medical research. Because it is an early example of using new technology to gather evidence, the findings should be viewed as part of a larger research process. You should always talk with your doctor about the best nutrition plan for a newborn.
What this means for you:
Bovine milk based fortifiers showed similar outcomes to human milk based fortifiers for certain newborn conditions.
Common questions
Are bovine milk fortifiers safe for pre-term babies?
The study looked at 3,371 publications regarding pre-term newborns. It found that bovine milk based fortifiers (BMF) were not inferior to human milk based fortifiers (HMF) when looking at outcomes for necrotizing enterocolitis and sepsis. This suggests BMF is a comparable option in these specific cases.
How does bovine milk compare to human milk for newborns?
This analysis focused on fortifiers used for pre-term babies with necrotizing enterocolitis or sepsis. The results showed that bovine milk based fortifiers (BMF) performed similarly to human milk based fortifiers (HMF). No specific adverse events were reported in the data provided.
Is this a new way of treating newborn infections?
The study was a proof of concept for using AI tools to help gather and summarize medical research. While it showed that bovine milk fortifiers are comparable to human milk ones, the primary goal was testing a new method for evidence synthesis in medicine.
Necrotizing enterocolitis (NEC), frequently resulting in sepsis, is among the leading causes of morbidity and mortality of pre-term newborns. However, diagnostic and therapeutic strategies for NEC and sepsis are still limited and controversial. In this context, there are ongoing debates regarding the application of human milk-based fortifiers (HMF) versus bovine milk-based fortifiers (BMF), but robust evidence is lacking. Systematic reviews and meta-analyses are expected to provide the highest level of evidence, but they are time-consuming and resource-intensive and are at risk of potential bias and subjectivity. The rapidly progressing large language model (LLM) artificial intelligence (AI) tools thus emerge as a promising complementary methodology for systematic review and meta-analysis. We conceptualized a cross-LLM AI platform meta-research and evidence synthesis workflow, leveraging 3 representative state-of-the-art platforms, ChatGPT, Claude and Manus AI. We analyzed 3371 PubMed-indexed publications. 3 platforms reported highly concordant findings. We found that prior systematic reviews and meta-analyses generally reported mixed findings comparing HMF versus BMF. Our LLM AI-assisted meta-research and evidence synthesis found non-inferiority of BMF to HMF for NEC and sepsis outcomes. Here, we present an unbiased direct head-to-head comparison between HMF and BMF in the context of NEC and sepsis. Our analyses also represent a proof-of-concept example for LLM AI-assisted meta-research and evidence synthesis, supporting the integration of LLM AI methodologies into evidence-based medicine and digital health.
